Support program for women recovering from ovarian cancer
Official title: POSTCARE-O: Survivorship Care for Women Living With Ovarian Cancer
Run by Baylor College of Medicine · NCT05752448 · Data updated 2026-11-12
This study is testing a new online support program for women who have finished treatment for ovarian cancer to see if it improves their quality of life compared to standard care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | Baylor College of Medicine Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 3 sites (Dallas, Texas and 2 other locations) |
| Status | Recruiting |
| Started | October 1, 2023 |
| Main results expected | July 1, 2026 |
| Study ends | April 15, 2027 |
| Registry record updated | April 3, 2026 |
| Trial ID | NCT05752448 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18 and older who have completed initial treatment for Stage 2-4 ovarian cancer within the last 6 months.
✕Probably not a fit
Patients who are admitted to hospice care at the completion of treatment will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to enroll 120 women who have completed initial treatment for Stage 2-4 ovarian cancer to evaluate the effectiveness of a telehealth-delivered survivorship care process called POSTCare-O. Participants will be randomly assigned to receive either the POSTCare survivorship care or standard care, with the primary focus on assessing quality of life at 12 weeks post-intervention. The study will utilize both quantitative and qualitative methodologies to gather comprehensive data on the impact of the intervention. Outcomes will be measured at baseline, 12 weeks, and 24 weeks to provide insights into the survivorship transition experience.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life for women recovering from ovarian cancer.
How similar studies have gone: Other studies have shown promise in using telehealth for cancer survivorship care, making this approach both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Stage 2-4 ovarian cancer * Treated with some combination of surgery, chemotherapy, biologics, maintenance therapy * Within 6 months of completion of initial treatment (continued maintenance therapy okay) * Able to provide consent in English or Spanish Exclusion Criteria: * Admission to hospice at the completion of treatment for ovary cancer
Where it's running
-
Dan L Duncan Comprehensive Cancer Center at the O'Quinn Medical Tower at Baylor St. Luke's Medical Center
Houston, Texas, United States Recruiting -
Harris Health Smith Clinic
Houston, Texas, United States Recruiting -
UT Southwestern Parkland Health and Hospital System
Dallas, Texas, United States Not yet recruiting
Study contacts
- Principal investigator: Elizabeth Kvale, MD,MPH — Baylor College of Medicine
- Study coordinator: Nimrah Saleem, MPH
- Email: nsaleem@bcm.edu
- Phone: 713-798-2272
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Morning Activation to Boost Mood After Stroke
A six-week behavioral program is tested to see if it helps mood and daily functioning in adults who had a stroke and feel depressed or slow to get going in the morning.
-
Sleep More, Stress Less with Neuralli Mood
This 90-day, open-label study tests whether daily Neuralli Mood capsules can help adults feel less stressed, sleep better, and improve mood and burnout symptoms.
-
Blended Baduanjin and Green Tea Program for Depressive Symptoms in Older Adults
This study tests whether a 12-week combo of gentle Baduanjin exercise and green tea consumption can help reduce depressive symptoms and improve gut health and quality of life in Hong Kong’s community-dwelling adults aged 65–84.
-
Metformin added to antidepressants for depression with obesity in Pakistani adults
This study tests whether adding metformin to antidepressant therapy helps reduce depressive symptoms and BMI in adults with depression and overweight/obesity in Pakistan.
-
rTMS with aerobic exercise for older adults with mild cognitive impairment and depressive symptoms
This trial tests whether rTMS alone or rTMS plus stationary cycling can improve thinking skills and mood in older adults with MCI and depression.
-
Subanesthetic Ketamine for Depressive Symptoms in ICU Patients
This study tests whether a short course of low-dose ketamine can help reduce depressive symptoms in adults who are in the ICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.